NRx Pharmaceuticals Q4 Earnings Call Highlights

Chronological Source Flow
Back

AI Fusion Summary

NRx Pharmaceuticals reported Q4 earnings, noting revenue growth, solid EPS, and positive guidance. The call highlighted progress on key drug candidates, regulatory milestones, and strategic initiatives to expand market presence.
24/03 15:10 yahoo.com
3 Πηγές
24/03 16:51 yahoo.com
24/03 16:51 yahoo.com
Comments
Loading...
0